Neurocrine Biosciences
$12.19 B
Share price
Change (1 day)
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: $12.19 Billion

As of December 2022 Neurocrine Biosciences has a market cap of $12.19 Billion. This makes Neurocrine Biosciences the world's 1267th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 2001 to 2022

End of year Market Cap

Year Market cap Change
2022$12.19 B50.88%
2021$8.07 B-9.78%
2020$8.95 B-9.71%
2019$9.91 B52.97%
2018$6.48 B-5.57%
2017$6.86 B104.23%
2016$3.36 B-31.11%
2015$4.87 B185.67%
2014$1.70 B171.56%
2013$0.62 B26.57%
2012$0.49 B5.82%
2011$0.46 B12.02%
2010$0.41 B250.42%
2009$0.11 B-3.12%
2008$0.12 B-28.92%
2007$0.17 B-56.01%
2006$0.39 B-83.04%
2005$2.32 B29.33%
2004$1.80 B-6.48%
2003$1.92 B37.56%
2002$1.40 B-10.09%
2001$1.55 B

End of Day market cap according to different sources

On Dec 2nd, 2022 the market cap of Neurocrine Biosciences was reported to be:

$12.03 Billion
by Yahoo Finance
$12.19 Billion
by CompaniesMarketCap
$12.19 Billion
by Nasdaq
$12.19 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$285.77 B 2,244.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$289.42 B 2,274.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$356.08 B 2,820.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.33 B-15.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.92 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.67 B-94.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.51 M-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.41 B 59.26%๐Ÿ‡ฌ๐Ÿ‡ง UK